Related Experiment Video
Updated: Aug 9, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes
T P Condon1, S Flournoy, G J Sawyer
1Isis Pharmaceuticals, Carlsbad, CA 92008, USA. tcondon@isisph.com
Abstract:
The release of tumor necrosis factor-alpha (TNF-alpha) from cellular membranes has been shown by different laboratories to be controlled by a disintegrin and metalloprotease, ADAM10 or ADAM17. In contrast, only ADAM17 has shown to be involved in L-selectin shedding. To determine the specific roles of ADAM10 and ADAM17 in the processing of TNF-alpha and L-selectin shedding, antisense oligonucleotides (ASO) targeting both ADAM10 and ADAM17 were identified. We show that ISIS 16337 reduces ADAM17 mRNA and ISIS 100750 reduces ADAM10 mRNA in a sequence-specific and dose-dependent manner in both Jurkat and THP-1 cells. The ADAM17 ASO (ISIS 16337) inhibited both TNF-alpha secretion in THP-1 cells and L-selectin shedding in Jurkat cells, whereas the ADAM10 ASO (ISIS 100750) did not significantly inhibit release of either protein. These results suggest that ADAM17 is one of the major metalloproteases involved in L-selectin shedding as well as TNF-alpha processing. The biologic substrates for ADAM10 in Jurkat and THP-1 cells remain to be elucidated.
Insights
ADAM17, but not ADAM10, is the primary metalloprotease responsible for tumor necrosis factor-alpha (TNF-alpha) secretion and L-selectin shedding. Antisense oligonucleotides confirmed ADAM17
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Tumor necrosis factor-alpha (TNF-alpha) and L-selectin shedding are regulated by metalloproteases.
- ADAM10 and ADAM17 are implicated in TNF-alpha release, while ADAM17 is linked to L-selectin shedding.
- The precise roles of ADAM10 and ADAM17 in these processes require further elucidation.
Purpose of the Study:
- To delineate the specific functions of ADAM10 and ADAM17 in TNF-alpha processing and L-selectin shedding.
- To validate the efficacy of antisense oligonucleotides (ASOs) in targeting ADAM10 and ADAM17.
Main Methods:
- Development and application of sequence-specific antisense oligonucleotides (ASOs) targeting ADAM10 and ADAM17.
- Treatment of Jurkat and THP-1 cells with ASOs to assess mRNA reduction.
- Quantification of TNF-alpha secretion and L-selectin shedding following ASO treatment.
Main Results:
- ISIS 16337 effectively reduced ADAM17 mRNA levels in a dose-dependent manner in both cell lines.
- ISIS 100750 specifically reduced ADAM10 mRNA levels in a dose-dependent manner.
- ADAM17 ASO (ISIS 16337) significantly inhibited TNF-alpha secretion and L-selectin shedding, whereas ADAM10 ASO (ISIS 100750) showed no significant effect.
Conclusions:
- ADAM17 is identified as a major metalloprotease responsible for both TNF-alpha processing and L-selectin shedding.
- ADAM10's specific biological substrates in Jurkat and THP-1 cells remain to be identified.
- ASOs targeting ADAM17 provide a potential strategy for modulating these shedding processes.
Related Concept Videos
The Tumor Microenvironment
Selectins

